Spontaneous bacterial peritonitis causing Serratia marcescens and Proteus mirabilis ventriculoperitoneal shunt

Luis M Tumialán1, Franklin Lin, Sanjay K Gupta

  • 1Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. ltumial@emory.edu

Journal of Neurosurgery
|January 16, 2007
PubMed

Insights

This study details treating a rare polymicrobial ventriculoperitoneal shunt infection caused by Serratia marcescens and Proteus mirabilis. Intrathecal gentamicin was crucial for resolving the infection, highlighting its importance in first-line therapy.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Medical Case Study

Background:

  • Ventriculoperitoneal (VP) shunts are common in treating hydrocephalus.
  • VP shunt infections can lead to significant morbidity and mortality.
  • Polymicrobial infections, especially with rare organisms, pose treatment challenges.

Observation:

  • A 21-year-old woman with developmental delay presented with a polymicrobial VP shunt infection.
  • Cerebrospinal fluid (CSF) cultures identified Serratia marcescens and Proteus mirabilis.
  • Abdominal examination and imaging ruled out bowel perforation or pseudocyst formation.

Findings:

  • The patient received intravenous gentamicin and imipenem/cilastatin, plus intrathecal gentamicin.
  • The infection resolved, and the VP shunt was successfully reimplanted.
  • Serratia marcescens is a rare and devastating cause of CNS infections, with only two prior reported cases.

Implications:

  • Intrathecal gentamicin should be strongly considered for S. marcescens VP shunt infections.
  • The findings suggest spontaneous bacterial peritonitis as a potential source of infection.
  • This case underscores the need for aggressive and targeted therapy in rare CNS infections.